Xcout Intel
CIRC Biosciences, Inc.
CiRC Biosciences is a privately held regenerative medicine and cell therapy company founded in 2019 and based in Chicago, Illinois, focused on developing cellular reprogramming solutions for degenerative diseases.
Subscribe to see CIRC Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CIRC Biosciences, Inc. at a glance
CIRC Biosciences, Inc. is a biotech company headquartered in United States. It has raised at least $24.1M across the 3 funding rounds on record. Its most recent funding round raised $7M in April 2024. Xcout tracks 5 named people at CIRC Biosciences, Inc., including Cole Ikkala (Interim CEO).
CIRC Biosciences, Inc. leadership
- Cole IkkalaInterim CEO
- Patrick J. MorrisPresident, Secretary and General Counsel
- Darien ParhadChief Financial Officer
- Brahim DomianChief Scientific Officer
- Stephen WanaskiSVP, Research & Exploratory Development
CIRC Biosciences, Inc. funding rounds
At least $24.1M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $7M | — | |
| SEC Form D filing | $250,000 | — | |
| SEC Form D filing | $16.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Get CIRC Biosciences, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on CIRC Biosciences, Inc. in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access